Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-20

Clinical Trial Update: A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON

View source ↗

Summary

A completed safety study evaluating FIRMAGON in patients with advanced prostate cancer has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Firmagon (Degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Status: COMPLETED | Results posted: 2019-05-20